Hiroaki Suga is a Professor of the Department of Chemistry, Graduate School of Science in the University of Tokyo. He received his Bachelor of Engineering (1986) and Master of Engineering (1989) from Okayama University, and Ph. D. in Chemistry (1994) from the Massachusetts Institute of Technology. After three years of post-doctoral work in Massachusetts General Hospital, he became Assistant Professor in the Department of Chemistry in the State University of New York at Buffalo (1997) and promoted to the tenured Associate Professor (2002). In 2003, he moved to the Research Center for Advanced Science and Technology in the University of Tokyo. In 2010, he changed his affiliation to the Department of Chemistry, Graduate School of Science. He is the recipient of Akabori Memorial Award 2014, Japanese Peptide Society, Max-Bergmann Gold Medal 2016, Vincent du Vigneaud Award 2019, The Research Award of the Alexander von Humboldt Foundation 2020, MIT T.Y. Shen Lectureship 2022, ETHZ Prelog Medal Lecture 2022, Wolf Prize in Chemistry 2023 and Japan Academy Prize 2024. He is also a founder of PeptiDream Inc. Tokyo, a publicly traded company in the Tokyo stock market, having many partnerships with pharmaceutical companies in worldwide. He is also a founder of MiraBiologics Inc. since 2017.